BrainStorm Cell Therapeutics to Provide Corporate Mid-Year Update on NurOwn Program

A conference call and webcast will be held Monday, July 8, at 8:00 a.m. Eastern Time

NEW YORK, July 1, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it will hold a mid-year corporate update to discuss recent positive developments in the NurOwn® program on Monday, July 8, at 8:00 a.m. U.S. Eastern Time.

Read more at prnewswire.com